Activated changes of platelet ultra microstructure and plasma granule membrane protein 140 in patients with non-small cell lung cancer
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 9
- DOI:
- 10.3760/cma.j.issn.0366-6999.2009.09.005
- Key Word:
- platelet;ultra microstructure;granule membrane protein 140;non-small cell lung cancer;P-selectin;a-granule
Abstract： Background Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality worldwide. Platelet activation may play an important role in pathologic progress in lung cancer. In this study, we aimed to clarify the influence of activated platelets on lung cancer generation and growth, and the relationship among these functional and ultrastructural changes of platelets and the severity of pathogenetic condition in these patients with NSCLC.Methods One hundred and thirty-six cases of patients with pathologically confirmed NSCLC were included in this study. Fifty-four healthy people were enrolled as controls. The change of ultra microstructure and activity of blood platelets were observed under the transmission and scanning electron microscope. Simultaneous determination of plasma granule membrane protein 140 (GMP-140) was made.Results Transmission electron microscopy showed remarkable changes of ultra microstructure of platelets in patients with NSCLC, including swelling, increase of o-granules, vesicles, and glycogenosome. Scanning electron microscopy showed many more surface processes and wrinkles on platelets in patients with NSCLC. The reference plasma levels of GMP-140 of healthy controls were (18.2±2.7) μg/L. The plasma levels of GMP-140 in patients with NSCLC were (47.8±12.3) μg/L, which were much higher than those of the controls. There was a medium positive correlation between plasma levels of GMP-140 and amount of o-granules (r=0.514, P<0.01) and a high positive correlation between plasma levels of GMP-140 and area of platelet (r=0.84, P<0.01) in patients with NSCLC. The Kaplan-Meier survival curve analysis showed significant shift to the left in patients with NSCLC whose α-granules per platelet were 19 or more compared to those 18 or less (Log rank statistic, X2=17.38, P <0.01).Conclusions There are significant activated changes of ultra microstructure and increased activity of blood platelets in patients with NSCLC. These activated platelets may play an important role in the generation and growth of lung cancer. These changes can be used as a diagnostic index of severity, progression, and prognosis of NSCLC.
- [1]WANG Meng-zhao,LI Long-yun,WANG Shu-Lan,etc.Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer[J].2006,(1).
- [2]LI Hong-li,WANG Tong-shan,LI Xiao-yu,etc.Overexpression of cyclin L2 induces apoptosis and cell-cycle arrest in human lung cancer cells[J].2007,(10).
- [3]ZHANG Zhen-jiang,CHEN Jing-han,MENG Long,etc.18F-FDG uptake as a biologic factor predicting outcome in patients with resected non-small-cell lung cancer[J].2007,(2).
- [4]XIE Guang-shun,HOU Ai-rong,LI Long-yun,etc.Aberrant p16 promoter hypermethylation in bronchial mucosae as a biomarker for the early detection of lung cancer[J].2006,(17).
- [5]Matsunaga K,Iijima H,Ishihara Y,etc.Expression of matrix metalloproteinase, tissue inhibitors of metalloproteinase and adhesion molecules in silicotic mice with lung tumor metastasis.[J].2003,142(1).
- [6]Borsig L,Varki A,Varki NM,etc.P-selectin deficiency attenuates tumor growth and metastasis.[J].1998,95(16).
- [7]Gunay Aygun M,Huizing M,Gahl WA.Molecular defects that affect platelet dense granules.[J].2004,30(5).
- [8]J H, Hartwig.Mechanisms of actin rearrangements mediating platelet activation.[J].1992,118(6).
- [9]Koda M,Banno Y,Naganawa T.Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.[J].2005,16(8).
- [10]D'Alessandro R,Paolo Gazzaniga P,Martini F,etc.Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers.[J].2003,89(1).
- [11]K V, Honn,D G, Tang,J D, Crissman.Platelets and cancer metastasis: a causal relationship?[J].1992,11(3-4).
- [12]P, Harrison,E M, Cramer.Platelet alpha-granules.[J].1993,7(1).
- [13]Rhee JS,Black M,Schubert U,etc.The functional role of blood platelet components in angiogenesis.[J].2004,92(2).
- [14]C F, Mountain.Revisions in the International System for Staging Lung Cancer.[J].1997,111(6).
- [15]Tan KT,Lip GY.The assessment of platelet activation in antiplatelet drug development.[J].2005,12(26).
- [16]Salgado R,Benoy I,Dirix L,etc.Platelets and vascular endothelial growth factor (VEGF): a morphological and functional study.[J].2001,4(1).
- [17]B, Lages,I I, Sussman,S P, Levine,etc.Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (alpha-storage pool deficiency).[J].1997,129.